A new synthetic version of the widely used anticoagulant heparin developed at the University of North Carolina at Chapel Hill can now be made in commercially viable quantities and promises to be safer than existing drugs. It is ready to … Read more

Faculty at the UNC Eshelman School of Pharmacy hosted four students from University College London School of Pharmacy as part of the international PharmAlliance partnership. All final-year pharmacy students at UCL are required to complete three months of research. PharmAlliance … Read more